INFORMAZIONI SU QUESTO EPISODIO
Can Advanced Engineered Materials (ASX) capitalise on rapidly growing demand for high-purity alumina across semiconductors, AI infrastructure and advanced technology?
In this episode of the Homodeus Research Podcast, Executive Chair Richard Seville and CEO & Managing Director Mick Adams discuss AEM's high-purity alumina (HPA) business and its commercial-scale production plant in Cap-Chat, Quebec.
Richard and Mick explain why HPA is becoming increasingly important across semiconductors, advanced ceramics, thermal management and synthetic sapphire, and how the growth of AI and data centres is contributing to demand for increasingly high-purity materials.
The discussion covers AEM's 4N+ and ultra-low-alpha HPA products, customer qualification process, commercial pipeline, pricing dynamics and the emerging global HPA supply shortage.
Management also outlines AEM's competitive cost position, access to low-cost renewable power in Quebec, Rio Tinto feedstock supply, plans to scale production and the longer-term pathway toward 6,000 tonnes of annual capacity.
The episode also explores semiconductor demand, geopolitical supply-chain shifts, commercial conversion of AEM's qualification pipeline, customer concentration, capital requirements and the company's pathway toward positive cash flow.
TOPICS COVERED
• What is high-purity alumina (HPA)?
• HPA applications in semiconductors and AI
• AEM's Cap-Chat production facility in Quebec
• 4N+, 5N and ultra-low-alpha HPA
• AI and data-centre demand
• Global HPA supply constraints
• Customer qualification and commercial conversion
• AEM's global cost position
• Low-cost renewable power from Hydro-Québec
• Rio Tinto feedstock supply
• Semiconductor and synthetic sapphire markets
• Expansion toward 6,000 tonnes of capacity
• Sales growth and customer pipeline
• Pathway toward positive cash flow
• Investor Q&A
In this episode of the Homodeus Research Podcast, Executive Chair Richard Seville and CEO & Managing Director Mick Adams discuss AEM's high-purity alumina (HPA) business and its commercial-scale production plant in Cap-Chat, Quebec.
Richard and Mick explain why HPA is becoming increasingly important across semiconductors, advanced ceramics, thermal management and synthetic sapphire, and how the growth of AI and data centres is contributing to demand for increasingly high-purity materials.
The discussion covers AEM's 4N+ and ultra-low-alpha HPA products, customer qualification process, commercial pipeline, pricing dynamics and the emerging global HPA supply shortage.
Management also outlines AEM's competitive cost position, access to low-cost renewable power in Quebec, Rio Tinto feedstock supply, plans to scale production and the longer-term pathway toward 6,000 tonnes of annual capacity.
The episode also explores semiconductor demand, geopolitical supply-chain shifts, commercial conversion of AEM's qualification pipeline, customer concentration, capital requirements and the company's pathway toward positive cash flow.
TOPICS COVERED
• What is high-purity alumina (HPA)?
• HPA applications in semiconductors and AI
• AEM's Cap-Chat production facility in Quebec
• 4N+, 5N and ultra-low-alpha HPA
• AI and data-centre demand
• Global HPA supply constraints
• Customer qualification and commercial conversion
• AEM's global cost position
• Low-cost renewable power from Hydro-Québec
• Rio Tinto feedstock supply
• Semiconductor and synthetic sapphire markets
• Expansion toward 6,000 tonnes of capacity
• Sales growth and customer pipeline
• Pathway toward positive cash flow
• Investor Q&A
Inglese
Australia
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di Homodeus Research.
ALTRI EPISODI IN QUESTO PODCAST
Could RareX (ASX) be entering a new phase as exploration at Khaleesi shows signs of a potential copper porphyry system while the company advances its broader rare earths and critical minerals strategy?
In this episode of the Homodeus Research Podcast, RareX Managing Director James Durrant discusses…
Neurizon Therapeutics (ASX) is approaching a critical period in the development of NUZ-001 for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease (MND).
In this episode of the Homodeus Research Podcast, Interim Executive Chair Sergio Duchini and CFO Dan O'Connell disc…
Can Aureka Limited (ASX) transform from a Victorian gold explorer into a producer while continuing to advance its larger growth projects?
In this episode of the Homodeus Research Podcast, Managing Director James Gurry discusses Aureka’s proposed acquisition of High Grade Holdings and Core Prospecti…
Can Dimerix build a global kidney disease business around two clinical-stage drug candidates?
Dimerix (ASX: DXB) Managing Director and CEO Nina Webster joins Homodeus Research to discuss the company’s kidney disease pipeline, led by DMX200 and DMX652.
DMX200 is being evaluated as a potential treatm…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Homodeus Research, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
